deltatrials
Completed PHASE1/PHASE2 NCT01505868

Cabazitaxel With or Without Carboplatin in Treating Patients With Previously Treated Metastatic Castration-Resistant Prostate Cancer

An Open Label Phase I/II Study of Cabazitaxel With or Without Carboplatin in Patients With Metastatic Castration-Resistant Prostate Cancer

Sponsor: M.D. Anderson Cancer Center

Conditions Castration Levels of Testosterone Castration-Resistant Prostate Carcinoma Lymphadenopathy Metastatic Prostate Carcinoma Prostate Adenocarcinoma Prostate Carcinoma Metastatic in the Bone Prostate Small Cell Carcinoma
Interventions Cabazitaxel Carboplatin Laboratory Biomarker Analysis
Updated 11 times since 2017 Last updated: Jul 29, 2021 Started: Jul 11, 2012 Primary completion: Dec 9, 2019 Completion: Dec 9, 2019

This PHASE1/PHASE2 trial investigates Castration Levels of Testosterone and Castration-Resistant Prostate Carcinoma and is currently completed. M.D. Anderson Cancer Center leads this study, which shows 11 recorded versions since 2012 — indicating substantial longitudinal coverage. As an oncology study, it adds to the longitudinal record of treatment development for this indication.

Change History

11 versions recorded

  1. Sep 2024 — Present [monthly]

    Completed PHASE1/PHASE2

  2. Jul 2024 — Sep 2024 [monthly]

    Completed PHASE1/PHASE2

    Phase: PHASE1_PHASE2 → PHASE1/PHASE2

  3. Sep 2021 — Jul 2024 [monthly]

    Completed PHASE1_PHASE2

  4. Jan 2021 — Sep 2021 [monthly]

    Completed PHASE1_PHASE2

  5. Dec 2020 — Jan 2021 [monthly]

    Completed PHASE1_PHASE2

    Status: Active Not Recruiting → Completed

▶ Show 6 earlier versions

  1. Jan 2020 — Dec 2020 [monthly]

    Active Not Recruiting PHASE1_PHASE2

  2. Nov 2018 — Jan 2020 [monthly]

    Active Not Recruiting PHASE1_PHASE2

  3. Jun 2018 — Nov 2018 [monthly]

    Active Not Recruiting PHASE1_PHASE2

  4. Jul 2017 — Jun 2018 [monthly]

    Active Not Recruiting PHASE1_PHASE2

  5. Feb 2017 — Jul 2017 [monthly]

    Active Not Recruiting PHASE1_PHASE2

  6. Jan 2017 — Feb 2017 [monthly]

    Active Not Recruiting PHASE1_PHASE2

    First recorded

Jul 2012

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • M.D. Anderson Cancer Center
  • National Cancer Institute (NCI)
Data source: M.D. Anderson Cancer Center

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

  • • Detroit, United States
  • • Houston, United States